Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuen Mei See
Observed names:
Y M See,
Yuen-Mei See
Institution:
Institute of Mental Health
Observed institutions:
Centre for Addiction and Mental Health,
National University of Singapore,
University of Toronto,
Duke-NUS Medical School,
Institute of Mental Health
ORCID:
0000-0002-2022-463X
Observed ORCID:
0000-0002-2022-463X
OpenAlex ID:
A5017659815
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
2017
·
Keane Lim
, Yuen Mei See
, et al.
·
Clinical Psychopharmacology and Neuroscience
·
194
PDF
Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia
2021
·
Keane Lim
, Oon-Him Peh
, et al.
·
Asian Journal of Psychiatry
·
106
PDF
Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study
2017
·
New Fei Ho
, Daphne J Holt
, et al.
·
Neuropsychopharmacology
·
85
PDF
Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia
2018
·
Zixu Yang
, Nur Amirah Abdul Rashid
, et al.
·
Schizophrenia Research
·
82
PDF
Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis
2018
·
Max Lam
, Jimmy Lee
, et al.
·
JAMA Psychiatry
·
78
PDF
Predicting Real-World Functioning in Schizophrenia: The Relative Contributions of Neurocognition, Functional Capacity, and Negative Symptoms
2021
·
Zixu Yang
, Soon Hong Lee
, et al.
·
Frontiers in Psychiatry
·
55
PDF
Investigation of Cigarette Smoking among Male Schizophrenia Patients
2013
·
Jundong Jiang
, Yuen Mei See
, et al.
·
PLoS ONE
·
43
PDF
Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia
2022
·
Yue Feng Quek
, Yuen Mei See
, et al.
·
Asian Journal of Psychiatry
·
27
Predicting antipsychotic responsiveness using a machine learning classifier trained on plasma levels of inflammatory markers in schizophrenia
2025
·
Jie Yin Yee
, Ser-Xian Phua
, et al.
·
Translational Psychiatry
·
25
PDF
Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis
2016
·
Jie Yin Yee
, Yuen Mei See
, et al.
·
Psychiatry Research
·
24
PDF
Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition
2024
·
Yanhui Li
, Mei San Ang
, et al.
·
Frontiers in Psychiatry
·
19
PDF
The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia
2023
·
Claire Law
, Yuen Mei See
, et al.
·
The Journal of Clinical Psychiatry
·
15
Association between treatment resistance and cognitive function in schizophrenia
2024
·
Jiaqian Sun
, Jie Yin Yee
, et al.
·
Singapore Medical Journal
·
11
Immunophenotyping schizophrenia subtypes stratified by antipsychotic response
2024
·
Yanhui Li
, Jocelyn Wen Xin Ong
, et al.
·
Brain Behavior and Immunity
·
10
Obsessive–compulsive symptoms and disorder in clozapine-treated schizophrenia
2023
·
Jonathan Gerard Hsueh Ching Seow
, Deborah Hui Yi Tan
, et al.
·
Revista de Psiquiatría y Salud Mental
·
8
Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore
2023
·
Zixu Yang
, Hiroyoshi Takeuchi
, et al.
·
Schizophrenia Research
·
8
Deconstructing the genetic architecture of treatment-resistant schizophrenia in East Asian ancestry
2023
·
Keane Lim
, Jie Yin Yee
, et al.
·
Asian Journal of Psychiatry
·
7
Correction: Progressive decline in hippocampal CA1 volume in individuals at ultra-high-risk for psychosis who do not remit: findings from the longitudinal youth at risk study
2019
·
New Fei Ho
, Daphne J. Holt
, et al.
·
Neuropsychopharmacology
·
2
PDF
F224. Utility of Saliva for Monitoring of Clozapine Levels
2018
·
Jimmy Lee
, Jie Yin Yee
, et al.
·
Schizophrenia Bulletin
·
2
PDF
Obesity Associated With Symptomatic Remission in Clozapine-Treated Individuals With Treatment-Resistant Schizophrenia
2025
·
Daniel Chang
, Yuen Mei See
, et al.
·
Journal of Clinical Psychopharmacology
·
1
Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia
2016
·
Nicholas Oh
, Yuen Mei See
, et al.
·
Journal of Clinical Psychopharmacology
·
1
Relationship Between Clozapine:Norclozapine Ratio, Cognitive Function, and Employment Status in Patients with Treatment-Resistant Schizophrenia
2025
·
Jiaqian Sun
, Jie Yin Yee
, et al.
·
Therapeutic Drug Monitoring
163. Relationship Between Clozapine: Norclozapine Ratio and Cognitive Function and Employment Status in Treatment Resistant Schizophrenia
2025
·
J Sun
, J Y Yee
, et al.
·
The International Journal of Neuropsychopharmacology
PDF
166. Haematological and Inflammatory Markers Associated With Non-remission and Treatment Resistance in Schizophrenia
2025
·
Y Li
, Y M See
, et al.
·
The International Journal of Neuropsychopharmacology
PDF
566. Obesity Associated With Symptomatic Remission in Clozapine-treated Individuals With Treatment Resistant Schizophrenia
2025
·
D Chang
, Y M See
, et al.
·
The International Journal of Neuropsychopharmacology
Show more works
View as search
Works count:
27
Citation count:
803
H-index:
12
I10-index:
14
Year
Topic
Type